Wide Ranks

MDGL

Madrigal Pharmaceuticals, Inc.

331.45

Top Statistics
Market Cap 7 B Forward PE -24.25 Revenue Growth 0.00 %
Current Ratio 5.98 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -11.60 Enterprise / Revenue 82.66 Price To Sales Trailing12 Months 94.11
Profitability
Profit Margins 0.00 % Operating Margins -187.06 %
Balance Sheet
Total Cash 998 M Total Cash Per Share 45.79 Total Debt 119 M
Total Debt To Equity 15.33 Current Ratio 5.98 Book Value Per Share 35.64
All Measures
Short Ratio 765.00 % Message Board Id finmb_144939852 Shares Short Prior Month 4 M
Return On Equity -1.30 City West Conshohocken Uuid 33c2338b-a0af-3dc0-8aac-f252490c3f9e
Previous Close 336.74 First Trade Date Epoch Utc 1 B Book Value 35.64
Beta -0.4690 Total Debt 119 M Volume 269299
Price To Book 9.30 Last Split Date 1 B Fifty Two Week Low 168.25
Total Cash Per Share 45.79 Total Revenue 76 M Shares Short Previous Month Date 1 B
Target Median Price 390.00 Max Age 86400 Recommendation Mean 1.76
Sand P52 Week Change 0.3133 Operating Margins -187.06 % Target Mean Price 372.20
Net Income To Common -518670016 Short Percent Of Float 0.2918 Implied Shares Outstanding 21 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 460510
Average Volume10days 460510 Total Cash 998 M Next Fiscal Year End 1 B
Revenue Per Share 3.71 Held Percent Insiders 0.0856 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 336.74
Target Low Price 155.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 258.66
Open 336.45 Free Cashflow -263114752 State PA
Dividend Yield 0.00 % Return On Assets -0.5225 Time Zone Short Name EST
Trailing Eps -25.02 Day Low 327.55 Address1 Four Tower Bridge
Shares Outstanding 21 M Price Hint 2 Target High Price 530.00
Website https://www.madrigalpharma.com 52 Week Change 0.6303 Average Volume 397739
Forward Eps -13.96 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 578.60 % Last Split Factor 1:35 Regular Market Day High 336.45
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 15.33
Fifty Two Week High 368.29 Day High 336.45 Shares Short 4 M
Regular Market Open 336.45 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue 82.66 Revenue Growth 0.00 % Shares Percent Shares Out 0.2033
Operating Cashflow -431019008 Currency USD Time Zone Full Name America/New_York
Market Cap 7 B Is_nasdaq_100 False Zip 19428
Quote Type EQUITY Industry Biotechnology Long Name Madrigal Pharmaceuticals, Inc.
Regular Market Day Low 327.55 Held Percent Institutions 1.06 Current Price 331.45
Address2 Suite 200 200 Barr Harbor Drive Enterprise To Ebitda -11.60 Financial Currency USD
Current Ratio 5.98 Gross Margins 96.37 % Industry Disp Biotechnology
Number Of Analyst Opinions 15 Country United States Float Shares 10 M
Two Hundred Day Average 251.28 Ir Website http://ir.syntapharma.com/phoenix.zhtml?c=147988&p=irol-irhome Enterprise Value 6 B
Price To Sales Trailing12 Months 94.11 Forward PE -24.25 Regular Market Volume 269299
Ebitda -547180032 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States.

Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH.

The company is headquartered in West Conshohocken, Pennsylvania.